0
After more than half a century of treating diabetics with animal insulins, recombinant DNA technologies and advanced protein chemistry made human insulin preparations available in the early 1980s. As the next step, over the last decade, insulin analogs were constructed by changing the structure of the native protein with the goal of improving the therapeutic properties of it, because the pharmacokinetic characteristics of rapid-, intermediate-, and long-acting preparations of human insulin make it almost impossible to achieve sustained normoglycemia. The first clinically available insulin analog, lispro, confirmed the hopes by showing that improved glycemic control can be achieved without an increase in hypoglycemic events. Two new insulin analogs, insulin glargine and insulin aspart, have recently been approved for clinical use in the United States, and several other analogs are being intensively tested. Thus, it appears that a rapid acceleration of basic and clinical research in this arena will be seen, which will have direct significance to both patients and their physicians. The introduction of new short-acting analogs and the development of the first truly long-acting analogs and the development of analogs with increased stability, less variability, and perhaps selective action, will help to develop more individualized treatment strategies targeted to specific patient characteristics and to achieve further improvements in glycemic control. Data on the currently available and tested analogs, as well as data on those currently being developed, are reviewed.
What else can I help you with?
What is a recombinant enzyme?
A recombinant enzyme is an enzyme that has been produced through genetic engineering techniques by inserting the gene encoding the enzyme into a host organism, such as bacteria or yeast, to facilitate its production in large quantities. These enzymes often offer improved stability, efficiency, and specificity compared to their naturally occurring counterparts.
What is the relationship between a transgenic organism and recombinant DNA?
a transgene is a gene that is not native to an organism (eg. it is a gene that is transferred from one organism to another)recombinant DNA is DNA that has essentially been combined with other, different DNA. DNA is double-stranded (the two strands are held together by basepair complementation). during recombination, the strands break apart, thus allowing another strand to bind with either of the original strands:original strandsDNA you want to insert into the organism (aka. a transgene) ]]you break apart the original strands | |and you add your strands |] |]now you have recombinant DNA, which is what a transgene will be when it has been integrated into an organism. it will (hopefully) be expressed correctly.(it's sliiightly more complicated than this haha, and the transgene can integrate (recombine) in numerous ways... but that's a solid foundational understanding of the process)hope this helps!NT
How is recombinant replicated?
Recombinant DNA is replicated using host cells, typically bacteria or yeast, that have been engineered to contain the desired DNA sequence. These host cells are then grown in a lab setting under specific conditions that allow for the replication of the recombinant DNA. The cell division process allows for the production of multiple copies of the recombinant DNA.
What organisms carry recombinant DNA in their genomes?
Organisms like bacteria, plants, and animals that have been genetically modified by incorporating recombinant DNA into their genomes can carry this modified genetic material. This allows them to exhibit new traits or characteristics that have been introduced through the genetic engineering process.
What is the different between recombinant DNA and non-recombinant DNA?
Recombinant DNA is created by combining DNA from different sources, such as different species, through techniques like genetic engineering. Non-recombinant DNA refers to DNA that has not been modified in this way and only contains genetic material naturally found in an organism.
Which diseases has already been helped by the use of recombinant DNA?
Diabetes and the lack of human growth hormone.
What technique has been possible only after development of recombinant DNA technology?
vaccinaton or immunisation
What is a DNA molecule containing regions from different sources?
A DNA molecule containing regions from different sources is called recombinant DNA. This is often created in laboratories by combining DNA from different organisms or through genetic engineering techniques. Recombinant DNA technology has many applications in biotechnology and genetic research.
Which type of DNA technology is used to cause bacteria to produce human insulin?
The type of DNA technology used to cause bacteria to produce human insulin is recombinant DNA technology. In this process, the gene for human insulin is inserted into the genome of a bacterium, such as Escherichia coli (E. coli), using techniques such as restriction enzymes and ligase enzymes. Once the gene is inserted, the bacterium is then able to produce human insulin, which can be purified and used for medical purposes. This technology has revolutionized the production of insulin, making it more accessible and affordable for people with diabetes. Recombinant DNA technology has also been used to produce many other human proteins, such as growth hormone and blood clotting factors, with great success.
What is a recombinant enzyme?
A recombinant enzyme is an enzyme that has been produced through genetic engineering techniques by inserting the gene encoding the enzyme into a host organism, such as bacteria or yeast, to facilitate its production in large quantities. These enzymes often offer improved stability, efficiency, and specificity compared to their naturally occurring counterparts.
E. coli that contains the genes for human insulin is?
E. coli that contains the gene for human insulin is genetically engineered, transgenic, and a GMO. Bacteria have been engineered to produce chymotrypsin, make human insulin, produce enzymes that increase shelf life of bread, and to produce enzymes that improve the taste and clarity of beer.
What is the essence of recombinant DNA?
Recombinant DNA is DNA this has been obtain from a source other then where it orginanated. In other words, a host has been used to create DNA from another organism.
What is rDNA technology?
Rdna is an abbreviation for recombinant DNA which meansDNA in which one or more segments or genes have been inserted, either naturally or by laboratory manipulation, from a different molecule or from another part of the same molecule, resulting in a new genetic combination.
What type of diabetes is most common in children and how can children treat their diabetes?
well i know from experience iv been diabetic for 10 yrs children get type 1 diabetes it is easily treatable with regular blood sugar readings and insulin injections see a doctor
What is a sticky end?
A Sticky End, referring to Biology is recombinant DNA. After DNA has been cut by a restriction enzyme it has "sticky ends" or recombinant DNA at the ends.
What is the Definition of recombinant proteins?
a protein encoded by a gene that has been cloned in a system that supports expression of the gene and translation of messenger RNA. Modification of the gene by recombinant DNA technology can lead to expression of a mutant protein. Proteins coexpressed in bacteria will not possess post-translational modifications, e.g. phosphorylation or glycosylation; eukaryotic expression systems are needed .
What should I know about natural treatments for diabetes?
The most natural way to treat diabetes is to control your diet and excersice regularly. If you have been put on medications you need to talk to you doctor about any alternative health plans you are thinking fo doing. People have reversed diabetes with changes to the diet.
